Hyporetic (Hydrochlorothiazide, Nebivolol)

Hydrochlorothiazide blocks sodium‑chloride reabsorption in the kidney’s distal tubule, increasing urine output and decreasing blood volume. Nebivolol selectively inhibits β1‑adrenergic receptors, slowing heart rate and contractility, while also stimulating nitric‑oxide release for vasodilation. Together they lower systemic vascular resistance and arterial pressure.

The appropriate dose of Hyporetic is individualized by a qualified prescriber based on the patient’s blood pressure, renal function, electrolyte status, and overall health. Clinicians consider these factors and may adjust the dose over time to achieve target blood‑pressure goals.

Safety data for Hydrochlorothiazide and Nebivolol in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any potential risk to the fetus or infant. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Hyporetic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent therapies, Hyporetic offers a dual mechanism—diuresis from Hydrochlorothiazide and β1‑blockade plus nitric‑oxide‑mediated vasodilation from Nebivolol. This can provide more robust blood‑pressure reduction in patients who need both volume control and heart‑rate reduction, potentially reducing the need for multiple separate pills.

Hyporetic tablets should be stored at ambient temperature, below 25 °C, in the original container. Protect them from moisture, direct sunlight and excessive heat to maintain stability and potency throughout the shelf‑life.

Hyporetic is taken orally as a tablet, usually with a full glass of water. It may be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether to take it at the same time each day for consistent blood‑pressure control.

Serious risks include severe hypotension, acute allergic reactions such as anaphylaxis, and pancreatitis. Electrolyte disturbances, particularly low potassium, can also become dangerous if not monitored. Patients should seek immediate medical attention if they experience symptoms like fainting, severe rash, or abdominal pain.

Hyporetic should be avoided in patients with known hypersensitivity to either component, severe renal or hepatic impairment, uncontrolled electrolyte imbalances, or those taking contraindicated medications such as certain lithium regimens. Clinicians must assess each individual’s medical history before prescribing.